Table 5 Seroprevalence of anti-dengue virus IgM and anti-dengue virus IgG stratified by age groups and citiesa
From: Retrospective Seroepidemiology study of dengue virus infection in Taiwan
Characteristics | Taipei | Taoyuan | Tainan | ||||
|---|---|---|---|---|---|---|---|
Seroprevalence (%) | 95% CI | Seroprevalence (%) | 95% CI | Seroprevalence (%) | 95% CI | ||
Age groups (years) | |||||||
0–9 | IgM | 1.76 | (1.29, 2.22) | 3.12 | (2.55, 3.68) | 4.73 | (3.45, 6.01) |
IgG | 0.93 | (0.59, 1.26) | 3.03 | (2.76, 3.30) | 1.58 | (0.82, 2.33) | |
10–19 | IgM | 0.00 | (0.00, 0.00) | 1.50 | (1.16, 1.84) | 0.00 | (0.00, 0.00) |
IgG | 0.00 | (0.00, 0.00) | 0.00 | (0.00, 0.00) | 4.48 | (3.61, 5.35) | |
20–29 | IgM | 1.15 | (0.88, 1.42) | 1.40 | (1.04, 1.77) | 1.84 | (1.29, 2.39) |
IgG | 0.00 | (0.00, 0.00) | 1.40 | (1.02, 1.79) | 4.69 | (3.83, 5.56) | |
30–39 | IgM | 0.81 | (0.64, 0.99) | 2.59 | (2.14, 3.05) | 1.55 | (1.10, 2.01) |
IgG | 4.07 | (3.69, 4.45) | 2.40 | (1.92, 2.87) | 3.11 | (2.47, 3.75) | |
40–49 | IgM | 1.16 | (0.87, 1.45) | 1.01 | (0.78, 1.25) | 2.90 | (2.34, 3.47) |
IgG | 1.16 | (0.87, 1.45) | 1.01 | (0.75, 1.27) | 0.00 | (0.00, 0.00) | |
50–59 | IgM | 2.78 | (2.41, 3.16) | 2.64 | (2.17, 3.11) | 0.00 | (0.00, 0.00) |
IgG | 2.78 | (2.41, 3.16) | 0.00 | (0.00, 0.00) | 0.00 | (0.00, 0.00) | |
60–69 | IgM | 2.27 | (1.75, 2.80) | 1.89 | (1.09, 2.69) | 0.00 | (0.00, 0.00) |
IgG | 3.41 | (2.77, 4.06) | 5.66 | (4.59, 6.74) | 18.92 | (15.62, 22.22) | |
≥ 70 | IgM | 13.84 | (8.43, 19.25) | 5.90 | (3.99, 7.82) | 0.00 | (0.00, 0.00) |
IgG | 34.1 | (26.74, 41.58) | 5.90 | (2.84, 8.97) | 41.31 | (37.66, 44.97) | |
Total | IgM | 1.75 | (1.70, 1.80) | 2.18 | (2.12, 2.25) | 1.50 | (1.43, 1.57) |
IgG | 2.76% | (2.70, 2.83) | 1.81% | (1.77, 1.86) | 6.64% | (6.49, 6.79) | |